Researchers in the field of psychedelics hit the ground running at the turn of the new year. January brought with it the largest published clinical trial with psilocybin to date. While ketamine was shown to effectively treat patients with alcohol use disorder, the same can’t be said for PTSD. A host of reviews provide food for thought on a range of psychedelics and their mechanism of action.


Previous articlePsychedelic Bulletin: Patent Granted Covering DMT Vapes; Microdosing Produces “Negligible” Effects
Next articlePsyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility